SRS for HHT-BAVMs achieved high obliteration rates with minimal morbidity. Given the low rate of hemorrhage and favorable functional outcomes, SRS could be considered a safe and effective treatment option for this unique patient population.
Akiyama et al. (Thu,) studied this question.